PMC:7441788 / 29582-29927
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T125 | 29-37 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T303 | 130-142 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T162 | 130-142 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T123 | 29-37 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T208 | 0-345 | Sentence | denotes | An observational study in 80 COVID-19 patients evaluated the efficacy of HCQ (200 mg/3 times/day for 10 days) in combination with azithromycin (500 mg on the first day, 250 mg/day afterward for 5 days) and showed that all patients’ clinical symptoms were improved, except for one patient aged over 86 years who died due to critical illness [58]. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
1089 | 38-46 | Species | denotes | patients | Tax:9606 |
1090 | 222-230 | Species | denotes | patients | Tax:9606 |
1091 | 280-287 | Species | denotes | patient | Tax:9606 |
1125 | 73-76 | Chemical | denotes | HCQ | MESH:D006886 |
1126 | 130-142 | Chemical | denotes | azithromycin | MESH:D017963 |
1193 | 29-37 | Disease | denotes | COVID-19 | MESH:C000657245 |
1194 | 311-315 | Disease | denotes | died | MESH:D003643 |
1195 | 323-339 | Disease | denotes | critical illness | MESH:D016638 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T136 | 241-249 | http://purl.obolibrary.org/obo/OGMS_0000020 | denotes | symptoms |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T118 | 29-37 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1089 | 38-46 | Species | denotes | patients | Tax:9606 |
1090 | 222-230 | Species | denotes | patients | Tax:9606 |
1091 | 280-287 | Species | denotes | patient | Tax:9606 |
1125 | 73-76 | Chemical | denotes | HCQ | MESH:D006886 |
1126 | 130-142 | Chemical | denotes | azithromycin | MESH:D017963 |
1193 | 29-37 | Disease | denotes | COVID-19 | MESH:C000657245 |
1194 | 311-315 | Disease | denotes | died | MESH:D003643 |
1195 | 323-339 | Disease | denotes | critical illness | MESH:D016638 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T208 | 0-345 | Sentence | denotes | An observational study in 80 COVID-19 patients evaluated the efficacy of HCQ (200 mg/3 times/day for 10 days) in combination with azithromycin (500 mg on the first day, 250 mg/day afterward for 5 days) and showed that all patients’ clinical symptoms were improved, except for one patient aged over 86 years who died due to critical illness [58]. |